STANDARD BIOTOOLS INC. — Director's Dealing 2022

Apr 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-04-04

Reporting Person: Egholm Michael (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-04-04	Restricted Stock Units	$	A	786049	Acquired		Common Stock (786049.0)	Direct
2022-04-04	Stock Option (Right to Buy)	$3.99	A	4529773	Acquired	2032-04-04	Common Stock (4529773.0)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.

F3: The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter.